BIO-key Clears Final Hurdle: 1.24M Armistice Warrants Now Exercisable After Oct 30 Vote
BKYI sits 74% above its 52-week low of $1.55 on light trading volume (0.1× avg).
Summary
BIO-key's Amendment No. 1 registers 1,236,668 Armistice warrant shares for resale and confirms the October 30, 2026 stockholder approval that made the $4.06 warrants exercisable. The company gets no resale proceeds; up to $5.02 million only if the warrants are exercised for cash.
Key Events · Financing and Capital Events · BKYI
-
Stockholder Approval Unlocks 1.24M Warrants
At the annual meeting reconvened October 30, 2026, stockholders approved issuance of the 1,236,668 shares underlying the Armistice warrants, which are now exercisable at $4.06 through October 30, 2031.
-
Resale Registration, No Company Proceeds
All 1,236,668 shares are registered for resale by Armistice Capital Master Fund Ltd.; BIO-key receives none of the resale proceeds and bears roughly $14,189 in registration expenses.
-
Up to $5.02M Only on Cash Exercise
Full cash exercise at $4.06 would yield about $5,020,872.08 for working capital, but with the stock at $2.69 a cash exercise is uneconomic; cashless exercise would deliver no cash.
-
Overhang on a 2.04M Share Base
The registered shares equal roughly 38% of the 3,271,817 shares that would be outstanding after full exercise, against 2,035,149 shares outstanding as of October 28, 2026.
Analysis · BKYI · Technology
The October 30, 2026 stockholder vote removed the last condition on the 1,236,668 warrants Armistice received for exercising its old $10.20 warrants at $4.06. Those warrants are now live at $4.06 against a $2.69 stock price, so a cash exercise is unlikely near term — Armistice would be paying well above market. The realistic path is a cashless exercise or resale of the registered shares, which puts roughly 1.24 million shares of overhang on a company with only 2,035,149 shares outstanding. The $5.02 million of potential cash would be meaningful runway for a company whose auditor flagged going-concern doubt, but it only arrives if the stock climbs above $4.06.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BKYI was trading at $2.69 on NASDAQ in the Technology sector, with a market capitalization of approximately $5.5M. The 52-week trading range was $1.55 to $13.80. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.